Cargando…
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Compuscript
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257320/ https://www.ncbi.nlm.nih.gov/pubmed/35765123 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0277 |
| _version_ | 1784741321514156032 |
|---|---|
| author | Li, Jianbin Jiang, Zefei |
| author_facet | Li, Jianbin Jiang, Zefei |
| author_sort | Li, Jianbin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9257320 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Compuscript |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92573202022-07-20 Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification Li, Jianbin Jiang, Zefei Cancer Biol Med Editorial Compuscript 2022-06-15 2022-06-29 /pmc/articles/PMC9257320/ /pubmed/35765123 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0277 Text en Copyright: © 2022, Cancer Biology & Medicine https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY) 4.0 (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. |
| spellingShingle | Editorial Li, Jianbin Jiang, Zefei Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification |
| title | Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification |
| title_full | Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification |
| title_fullStr | Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification |
| title_full_unstemmed | Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification |
| title_short | Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification |
| title_sort | chinese society of clinical oncology breast cancer (csco bc) guidelines in 2022: stratification and classification |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257320/ https://www.ncbi.nlm.nih.gov/pubmed/35765123 http://dx.doi.org/10.20892/j.issn.2095-3941.2022.0277 |
| work_keys_str_mv | AT lijianbin chinesesocietyofclinicaloncologybreastcancercscobcguidelinesin2022stratificationandclassification AT jiangzefei chinesesocietyofclinicaloncologybreastcancercscobcguidelinesin2022stratificationandclassification |